Top-News
Quelle: - pixabay.com:
Urgent Need for Early Detection in Drug Overdose Cases Highlighted in New Podcast
Episode 49 of QuidelOrtho Science Bytes explores substance use trends, the limits of Narcan, and the evolving challenges facing emergency departments
SAN DIEGO, July 24, 2025 /PRNewswire/ -- In emergency care settings, every second counts. Early drug detection not only improves clinical decision-making, it can be the difference between life and death. But with the rise of counterfeit medications and drug combinations that are more potent and less predictable, emergency departments must adapt faster than ever.
QuidelOrtho Science Bytes Episode 49 "How Urgent Diagnostic Testing Can Help Prevent Drug Overdose Deaths," addresses the escalating complexities of substance use detection and care in emergency departments across the country. The episode features Vonda McAllister, Director of Global Product Management at QuidelOrtho, whose deep experience in diagnostics and toxicology provides critical perspective on the clinical and societal impacts of today's most dangerous drug trends.
Episode Highlights:
- How rapid diagnostic testing is saving lives
- Understanding the unpredictable nature of polydrug overdoses
- The increasing prevalence of potent synthetic drugs like fentanyl, xylazine ("tranq"), and nitazines
- The limitations of Narcan (naloxone) and the rising need for repeated doses due to powerful opioid analogs
- California's "Tyler's Law," which mandates fentanyl testing in suspected overdose cases
Key Quotes:
Vonda McCallister, Director of Global Product Management, QuidelOrtho
"As overdose presentations become more complex, continuous monitoring, comprehensive toxicology screening and clinical vigilance are essential tools in the fight against this crisis."
About QuidelOrtho Science Bytes
Science Bytes is a monthly podcast that delivers diagnostic insights and innovation updates from QuidelOrtho, helping healthcare providers stay informed and prepared. Episode 49 is now available on all major podcast platforms.
For more information and to listen to the full episode, visit www.quidelortho.com/sciencebytes.
About QuidelOrtho Corporation
QuidelOrtho Corporation (Nasdaq: QDEL) is a global provider of innovative diagnostic testing solutions. From infectious diseases to cardiac biomarkers to women's health, QuidelOrtho transforms the power of diagnostics into a healthier future through science, innovation, and accessibility. Learn more at www.quidelortho.com.
Source: QuidelOrtho Corporation
| Investor Contact: Juliet Cunningham Vice President, Investor Relations
| Media Contact: D. Nikki Wheeler Senior Director, Corporate Communications
|
View original content to download multimedia:https://www.prnewswire.com/news-releases/urgent-need-for-early-detection-in-drug-overdose-cases-highlighted-in-new-podcast-302512078.html
SOURCE QuidelOrtho Corporation
Für dich aus unserer Redaktion zusammengestellt
Dein Kommentar zum Artikel im Forum
Jetzt anmelden und diskutieren
Registrieren
Login
Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.